Viewing Study NCT00137033


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT00137033
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2005-08-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module